Macter International Limited (PSX:MACTER)

Pakistan · Delayed Price · Currency is PKR

277.32

-0.04 (-0.01%)

At close: Aug 20, 2026

-28.32% (1Y)

Market Cap	12.70B -30.4%
Revenue (ttm)	11.95B +20.8%
Net Income	815.92M +33.5%
EPS	17.81 +33.9%
Shares Out	45.81M
PE Ratio	15.57
Forward PE	n/a
Dividend	2.00 (0.72%)
Ex-Dividend Date	Oct 16, 2025

Volume	2,719
Open	279.99
Previous Close	277.36
Day's Range	275.00 - 279.99
52-Week Range	255.10 - 443.50
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 22, 2026

About Macter International

Macter International Limited, a contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan. It offers Upacnet, Indyco M, Digebro Syrup, and SEGLUTIDE. The company provides pharmaceutical products in the areas of antibiotics, anti-allergy, cardiovascular, anti-viral, etc.; and consumer and biological products. It also offers solid and liquid oral dosage forms, such as tablets, capsules, syrups, suspensions, and dry powders. In addition, the company provides injections, including ... [Read more]

Industry Pharmaceuticals

Sector Healthcare

Founded 1992

Employees 1,282

Stock Exchange Pakistan Stock Exchange

Ticker Symbol MACTER

Full Company Profile

Financial Performance

In fiscal year 2025, Macter International's revenue was 10.36 billion, an increase of 29.91% compared to the previous year's 7.97 billion. Earnings were 776.43 million, an increase of 90.91%.

Financial Statements